Thursday, July 02, 2015 6:05:36 PM
BB
================================
Dear Mr. Williams,
I am very sorry to hear about your father, and hope he will have successful surgery and full convalescence. Both prevention and care of coronary artery disease has significantly improved in the US, and we at FDA will do our best to keep this field progressing. Janet Woodcock
-----Original Message-----
From: Jason Williams [mailto:jrwillixxxxx]
Sent: Wednesday, July 01, 2015 8:53 PM
To: Behr, Virginia L; Woodcock, Janet; badreddine Jasmine; Wright, John
Subject: Re: Heart Attack
On Jun 24, 2015, at 6:38 PM, Jason Williams <jrwillixxxxx> wrote:
Dr. Woodcock,
Today my father-in-law (ex-Amarin Investor) had an MI. He’s scheduled for a bypass next week (3-5) at St. Mary’s Hospital in Madison Wisconsin. His name is Thomas xxxxxxxxx, his wife is the superintendent of the xxxxxxx School District. His LDL was 106, HDL 26, Trigs 138…his only medication was OTC “fish oil”…the same crap you compare Vascepa to. Clearly his Trigs without the crappy fish oil would be well into the REDUCE-IT level.
Our entire family, including my two children…XXXXX 9 years old (awesome soccer player), my son XXXXX 12 (computer genius) observe other anxious family members as the day progressed…They got to see a grown man cry with the fear of losing his father. My brother-in-law was 13 years old when he got to witness his mothers death at their childhood home. She died in-expectantly due to an undiagnosed seizure disorder. My now grown bother-in-law 36 years old, who just had his first son XXXX (3 months), is having flashbacks of his father and Aunt coming up the driveway to tell him his mother passed away.
Janet, you are blinded…I don’t know or care why or how…but this must stop before other have to go through what I just described. I swear the above is true.
Senator Baldwin,
If the FDA or HHS budget makes it out of Committee without Amarin situation being FULLY resolved, I am personally holding you responsible for not taking more aggressive action against the FDA for the pure Regulatory Negligence they’ve asserted towards Vascepa/Amarin. During your summer break, stop by St. Mary’s and wish my father-in-law a swift recovery.
Sincerely,
Williams
Recent AMRN News
- Amarin to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference • GlobeNewswire Inc. • 05/06/2024 12:00:00 PM
- Amarin Reports First Quarter 2024 Business Update and Financial Results • GlobeNewswire Inc. • 05/01/2024 11:00:00 AM
- Amarin Applauds HealthyWomen’s Citizen’s Petition Urging FDA To Take Further Action On Fenofibrate Prescribing in Patients at Risk of Cardiovascular Event • GlobeNewswire Inc. • 04/24/2024 06:00:01 PM
- Amarin Announces Results of Annual General Meeting of Shareholders • GlobeNewswire Inc. • 04/22/2024 12:00:25 PM
- Amarin to Report First Quarter 2024 Financial Results and Host Conference Call on May 1, 2024 • GlobeNewswire Inc. • 04/15/2024 12:00:00 PM
- Amarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ACC.24 • GlobeNewswire Inc. • 04/08/2024 12:00:00 PM
- New REDUCE-IT® Analyses Show VASCEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups • PR Newswire (Canada) • 04/08/2024 10:30:00 AM
- New REDUCE-IT® Analyses Show VASCEPA®/VAZKEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups • GlobeNewswire Inc. • 04/06/2024 07:30:00 PM
- Amarin Provides Update on VAZKEPA® (Icosapent Ethyl) Intellectual Property Portfolio in Europe • GlobeNewswire Inc. • 04/03/2024 12:00:00 PM
- Research Evaluating Benefits of VASCEPA®/VAZKEPA® (icosapent ethyl) to be Presented at the American College of Cardiology’s (ACC) Annual Scientific Session & Expo • GlobeNewswire Inc. • 03/25/2024 12:00:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 03/04/2024 10:30:53 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/04/2024 01:00:24 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/29/2024 12:06:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 12:05:56 PM
- Amarin Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 02/29/2024 12:00:00 PM
- Amarin to Report Fourth Quarter and Full Year 2023 Financial Results and Host Conference on February 29, 2024 • GlobeNewswire Inc. • 02/15/2024 01:00:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 02/12/2024 01:00:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:31:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:30:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:30:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:30:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:30:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:30:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/26/2024 12:00:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/24/2024 09:31:21 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM